TRS heads into its May 20 earnings with short interest still elevated but on a clear downward trend — the key question is whether recent covering reflects conviction or simply a pause.
Short interest has pulled back sharply over the past month, falling roughly 12% to land at about 9.8% of the free float — or a cleaner 13% when measured against the estimated float figure from the database. Either way, that remains a meaningful short position for a mid-cap industrials name. The bulk of the retreat happened in a single session around April 23, when shares outstanding in the borrow dropped from above 4.6 million to roughly 3.9 million, a compression that accounts for almost all of the weekly decline of 12.3%. Despite that covering, the ORTEX short score of 62.2 remains solidly elevated, ranking in the 3rd percentile of the universe — meaning TRS is still among the more heavily bet-against names in the database.
Borrow conditions tell a relaxed story. Cost to borrow has drifted in a very narrow band all month, ending at just 0.45% — well below any level that would create squeeze pressure. Availability is wide, and utilization is running at 13%, far below the 52-week high of 23%, suggesting the lending pool is nowhere near stressed. Options positioning aligns with that picture: the put/call ratio of 0.044 is actually well below its 20-day average of 0.073, running more than one standard deviation light on puts. Investors are not paying up to hedge downside heading into the print.
The Street picture is constructive but thinly covered. BWS Financial has held a Buy with a $45 target throughout the year, and Keybanc carries an Overweight — though Keybanc did trim its target from $45 to $38 back in November 2025. With the stock at $36.08, both targets imply upside, but neither firm is a bellwether name, and there has been no fresh analyst action since early March. The bull case centres on TriMas's simplified structure after the aerospace divestiture, with the packaging segment driving the top-line beat last quarter. Bears counter that the same divestiture leaves the company heavily concentrated — packaging is now most of the revenue base, and any sector softness hits harder without the diversification buffer.
Factor scores add a nuanced layer. The EPS surprise rank of 98 is the standout — TriMas has a consistent history of beating estimates, which sets a high bar for the May print but also suggests management guides conservatively. The dividend score of 91 is solid, though the actual yield is negligible given the $0.04 quarterly payment, unchanged since 2021. On valuation, the EV/EBITDA of 9.7x has compressed modestly over 30 days, which is reasonable given the stock's 1% gain over the same period.
Inside the ownership register, the most notable detail is that Jefferies Financial Group entered with a 4.1% stake (1.55 million shares) at some point in the second half of 2025, a new position of that size. Allspring Global added 73,600 shares in Q1 2026, and Vanguard added 68,700. Those are modest incremental buys rather than aggressive builds. Insider activity has been net selling — the Acting CFO and General Counsel both sold in March — though the dollar values were small (below $250k combined) and the trades looked routine rather than signalling.
The last confirmed earnings release on April 28 was followed by a 4% one-day loss. The February 26 report delivered the opposite, with the stock gaining 6% on the day and holding most of that into the week. The peer group was broadly weaker on the day Wednesday, with MYE falling 6.6% and SW dropping 2.2%, so the sector backdrop heading into May is not particularly supportive. What to watch: whether the short covering of the past week accelerates or reverses after the May 20 print, and whether the EPS surprise streak holds against what will be the first full-quarter read on the post-aerospace structure.
See the live data behind this article on ORTEX.
Open TRS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
